Christian Dingler is an associate director within Guidehouse’s Life Sciences Governance, Risk Management and Compliance practice. He supports life science companies in the US and abroad implement, manage, and remediate compliance programs including those under government oversight. Christian is a frequent author and speaker on the subject of life science compliance best practices.
Christian has implemented compliance programs at pharmaceutical, medical device, and diagnostic companies, including the development of codes of conduct, policies, and procedures. He has implemented enterprise wide and therapeutic area risk assessments for clients and has developed auditing and monitoring plans to reduce operational risk. Christian served as an interim member of compliance departments of multiple emerging and established international life science companies.
Christian has extensive auditing and monitoring experience, including on behalf of government regulators as an Independent Review Organization (IRO) monitoring companies under Corporate Integrity Agreements (CIA). Additional auditing and monitoring experience includes conducting Pharmaceutical Research and Manufacturers of America (PhRMA) Code assessments; field force monitoring of field rides and speaker programs; prospective compliance gap assessments; FDA mock inspections; and prospective commercial compliance auditing.
Christian has broad project management, system implementation, and M&A experience, including the implementation of an enterprise wide aggregate spend system to comply with Sunshine Act / Open Payments and state reporting requirements. He led the implementation of systems to document need for physician consulting agreements and systems to contract with healthcare professionals. Christian has conducted due diligence on the compliance programs of potential acquisitions and has supported the post-deal integration of compliance programs.
Christian is an experienced writer who has supported expert reports surrounding payer, provider, pharmaceutical, and device litigations. He has supported the submission of FDA regulatory documents for drug and device manufacturers, and has drafted multiple reports reviewed by OIG and DOJ government monitors. Christian has authored thought leadership on life science compliance for the American Bar Association and Healthcare Information and Management Systems Society.
BA, Finance and Accounting, College of William & Mary